Gołembiowska K - Search Results

1

Hallucinogenic activity, neurotransmitters release, anxiolytic and neurotoxic effects in Rat's brain following repeated administration of novel psychoactive compound 25B-NBOMe.

Wojtas A, Herian M, Maćkowiak M, Solarz A, Wawrzczak-Bargiela A, Bysiek A, Noworyta K, Gołembiowska K. Wojtas A, et al. Among authors: golembiowska k. Neuropharmacology. 2023 Dec 1;240:109713. doi: 10.1016/j.neuropharm.2023.109713. Epub 2023 Sep 9. Neuropharmacology. 2023. PMID: 37689261

2

The role of striatal metabotropic glutamate receptors in Parkinson's disease.

Ossowska K, Konieczny J, Wardas J, Gołembiowska K, Wolfarth S, Pilc A. Ossowska K, et al. Among authors: golembiowska k. Amino Acids. 2002;23(1-3):193-8. doi: 10.1007/s00726-001-0128-0. Amino Acids. 2002. PMID: 12373537 Review.

3

Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.

Golembiowska K, White TD, Sawynok J. Golembiowska K, et al. Eur J Pharmacol. 1996 Jun 27;307(2):157-62. doi: 10.1016/0014-2999(96)00248-8. Eur J Pharmacol. 1996. PMID: 8832217

4

Preclinical evaluation of the abuse potential of the analgesic bicifadine.

Nicholson KL, Balster RL, Golembiowska K, Kowalska M, Tizzano JP, Skolnick P, Basile AS. Nicholson KL, et al. Among authors: golembiowska k. J Pharmacol Exp Ther. 2009 Jul;330(1):236-48. doi: 10.1124/jpet.109.150540. Epub 2009 Apr 8. J Pharmacol Exp Ther. 2009. PMID: 19357320 Free PMC article.

5

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain.

Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E. Basile AS, et al. Among authors: golembiowska k. J Pharmacol Exp Ther. 2007 Jun;321(3):1208-25. doi: 10.1124/jpet.106.116483. Epub 2007 Feb 26. J Pharmacol Exp Ther. 2007. PMID: 17325229

6

Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.

Bymaster FP, Golembiowska K, Kowalska M, Choi YK, Tarazi FI. Bymaster FP, et al. Among authors: golembiowska k. Synapse. 2012 Jun;66(6):522-32. doi: 10.1002/syn.21538. Epub 2012 Feb 22. Synapse. 2012. PMID: 22298359

7

Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors.

Golembiowska K, White TD, Sawynok J. Golembiowska K, et al. Brain Res. 1995 Nov 20;699(2):315-20. doi: 10.1016/0006-8993(95)00926-h. Brain Res. 1995. PMID: 8616636

8

Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats.

Chojnacka-Wójcik E, Tatarczyńska E, Gołembiowska K, Przegaliński E. Chojnacka-Wójcik E, et al. Among authors: golembiowska k. Neuropharmacology. 1991 Jul;30(7):711-7. doi: 10.1016/0028-3908(91)90178-e. Neuropharmacology. 1991. PMID: 1681449

9

Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex.

Wedzony K, Maćkowiak M, Fijał K, Gołembiowska K. Wedzony K, et al. Among authors: golembiowska k. Eur J Pharmacol. 1996 Jun 3;305(1-3):73-8. doi: 10.1016/0014-2999(96)00150-1. Eur J Pharmacol. 1996. PMID: 8813534

10

Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists.

Wedzony K, Maćkowiak M, Fijał K, Gołembiowska K. Wedzony K, et al. Among authors: golembiowska k. Synapse. 1996 Nov;24(3):240-7. doi: 10.1002/(SICI)1098-2396(199611)24:3<240::AID-SYN6>3.0.CO;2-E. Synapse. 1996. PMID: 8923664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page